结合中美欧的上市后变更管理制度
浅谈我国新版上市后化药变更指导原则
张保梅, 陆骁骏
Explaination of New Guideline for Post-approval Changes to Chemical Drug in
Combination with the Post-approval Change Managements in China,
the United States and Europe
ZHANG Baomei, LU Xiaojun
中国医药工业杂志
.
2022, (07): 1056
-1061
.
DOI: 10.16522/j.cnki.cjph.2022.07.020
